Compound Summary
Compound Name: | bromoenol lactone |
Compound CID: | 5940264 |
Synonyms: | bromoenol lactone 88070-98-8 HELSS BTNP BEL More... |
Iupac Name: | (6E)-6-(bromomethylidene)-3-naphthalen-1-yloxan-2-one |
InChI: | InChI=1S/C16H13BrO2/c17-10-12-8-9-15(16(18)19-12)14-7-3-5-11-4-1-2-6-13(11)14/h1-7,10,15H,8-9H2/b12-10+ |
InChIKey: | BYUCSFWXCMTYOI-ZRDIBKRKSA-N |
Canonical Smiles: | C1CC(=CBr)OC(=O)C1C2=CC=CC3=CC=CC=C32 |
Isomeric Smiles: | C1C/C(=C\Br)/OC(=O)C1C2=CC=CC3=CC=CC=C32 |
Molecular Weight: | 317.18 |
Molecular Formula: | C16H13BrO2 |
Molecular Weight: | 317.18 |
Molecular Formula: | C16H13BrO2 |
Hydrogen Bond Donor Count: | 0 |
Hydrogen Bond Acceptor Count: | 2 |
Rotatable Bond Count: | 1 |
Heavy Atom Count: | 19 |
Complexity: | 377 |
bromoenol lactone | bromoenol lactone |
---|---|
bromoenol lactone |
88070-98-8 |
HELSS |
BTNP |
BEL |
Haloenol lactone suicide substrate |
6-(Bromomethylene)tetrahydro-3-(1-naphthaleneyl)-2H-pyran-2-one |
(E)-6-(Bromomethylene)tetrahydro-3-(1-naphthalenyl)-2H-Pyran-2-one |
CHEMBL6206 |
C16H13BrO2 |
MFCD00270871 |
6-Btnpo |
bromoenolactone |
HELSS (Haloenol lactone suicide substrate, BEL, Bromoenol lactone) |
BROMOENOLLACTONE |
SR-01000075707 |
(6E)-6-(bromomethylidene)-3-naphthalen-1-yloxan-2-one |
6-(bromomethylene)tetrahydro-3-(1-naphthalenyl)-2H-pyran-2-one |
(E)-6-(Bromomethylene)-3-(1-naphthalenyl)tetrahydro-2H-pyran-2-one |
Lopac0_000150 |
GTPL5149 |
SCHEMBL2060001 |
SCHEMBL2060074 |
DTXSID001017361 |
E-6-(Bromoethylene)tetrahydro-3-(1-naphthyl)-2H-pyran-2-one |
HMS3649C04 |
Bromoenol lactone, >=98% (TLC) |
1643AH |
BDBM50046268 |
E-6-(Bromomethylene)tetrahydro-3-(1-naphthalenyl)-2H-pyran-2-one |
2H-Pyran-2-one, 6-(bromomethylene)tetrahydro-3-(1-naphthalenyl)-, (E)- |
CCG-204245 |
LP00150 |
SDCCGSBI-0050138.P002 |
NCGC00015141-02 |
NCGC00015141-03 |
NCGC00015141-04 |
NCGC00093640-01 |
NCGC00093640-02 |
HY-107411 |
CS-0028427 |
EU-0100150 |
SR-01000075707-1 |
SR-01000075707-5 |
Q27075527 |
(6E)-6-(bromomethylidene)-3-(naphthalen-1-yl)oxan-2-one |
6-Bromomethylene-3-naphthalen-1-yl-tetrahydro-pyran-2-one |
6E-(Bromomethylene)tetrahydro-3-(1-naphthalenyl)-2H-pyran-2-one |
BEL; E-6-(Bromoethylene)tetrahydro-3-(1-naphthyl)-2H-pyran-2-one |
(E)-6-(bromomethylene)-3-(naphthalen-1-yl)tetrahydro-2H-pyran-2-one |
6-1-Bromo-meth-(E)-ylidene-3-naphthalen-1-yl-tetrahydro-pyran-2-one |
Species | Dosage | Unit | CG Lifespan(AVG/MED days) | TG Lifespan(AVG/MED days) | Lifespan Change(AVG/MED%) | CG Lifespan(MAX days) | TG Lifespan(MAX days) | Lifespan Change(MAX%) | Significant | Strain | Gender | PubMed | Active Label |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Caenorhabditis elegans | 33 | umol/L | 21 | NS | N2 | 24134630 | Inactive |
Species | Lifespan Change(AVG/MED%) | Lifespan Change(MAX%) | Count Reference | Count Data point |
---|---|---|---|---|
Caenorhabditis elegans | 21 | 1 | 1 |